Back to User profile » Dr Shangli Cai
Papers published by Dr Shangli Cai:
Factors related to improvement of symptoms, function, and caregiver burden in Chinese patients with schizophrenia after switching to paliperidone palmitate once-monthly from oral antipsychotics
Li N, Feng Y, Lu HF, Cai SL, Zhuo JM, Si TM, Zhang LL
Neuropsychiatric Disease and Treatment 2018, 14:825-837
Published Date: 22 March 2018
Safety and efficacy of paliperidone palmitate 1-month formulation in Chinese patients with schizophrenia: a 25-week, open-label, multicenter, Phase IV study
Zhao JP, Li LH, Shi JG, Li Y, Xu XF, Li KQ, Zhang LL, Cai SL, Feng Y, Zhuo JM, Liu WH, Lu HF
Neuropsychiatric Disease and Treatment 2017, 13:2045-2056
Published Date: 2 August 2017
Treatment satisfaction with paliperidone extended-release tablets: open-label study in schizophrenia patients dissatisfied with previous antipsychotic medication
Yang FD, Li J, Tan YL, Liang WY, Zhang R, Wang N, Feng W, Cai S, Zhuo JM, Zhang LL
Neuropsychiatric Disease and Treatment 2017, 13:1089-1097
Published Date: 13 April 2017
Paliperidone extended-release tablets in Chinese patients with schizophrenia: meta-analysis of randomized controlled trials
Cai SL, Lu HF, Bai ZH, Wu RR, Zhao JP
Neuropsychiatric Disease and Treatment 2015, 11:1817-1834
Published Date: 23 July 2015